Research Article
Cu(II) and Ni(II) Complexes with New Tridentate NNS Thiosemicarbazones: Synthesis, Characterisation, DNA Interaction, and Antibacterial Activity
Table 5
Antibacterial activities of the studied compound.
| | Compound | MIC (μg·mL−1) | | S. aureusATCC 25923 | L. monocytogenesATCC 19115 | B. cereusATCC 10876 | E. coliATCC 25922 | S. typhimuriumATCC 14028 | K. pneumoniaeATCC BAA-2146 |
| | Cu(NO3)2 | >2000 | >2000 | >2000 | >2000 | >2000 | >2000 | | Ni(NO3)2 | >2000 | >2000 | >2000 | >2000 | >2000 | >2000 | | H2L1 | 500 | 1000 | 500 | 500 | 1000 | 2000 | | H2L2 | 500 | 2000 | 500 | >2000 | 2000 | >2000 | | 1 | 3.9 | 15.5 | 3.9 | 63 | 125 | 500 | | 2 | 3.9 | 31.3 | 3.9 | 125 | 2000 | >2000 | | 3 | 63 | 125 | 125 | 1000 | >2000 | >2000 | | 4 | 125 | 125 | 125 | 1000 | >2000 | 2000 | | Cip | 0.5 | 0.5 | 0.5 | <0.008 | 0.125 | >4 | | AgNO3 | <100 | <100 | <100 | <100 | <100 | <100 |
|
|
MIC: minimum inhibitory concentration; Cip: ciprofloxacine; AgNO3: reference/medication control.
|
